These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial. Ribera JM, Oriol A, Bethencourt C, Parody R, Hernández-Rivas JM, Moreno MJ, del Potro E, Torm M, Rivas C, Besalduch J, Sanz MA, Ortega JJ, PETHEMA Group, Spain. Haematologica; 2005 Oct; 90(10):1346-56. PubMed ID: 16219571 [Abstract] [Full Text] [Related]
3. Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial. Ribera JM, Ortega JJ, Oriol A, Bastida P, Calvo C, Pérez-Hurtado JM, González-Valentín ME, Martín-Reina V, Molinés A, Ortega-Rivas F, Moreno MJ, Rivas C, Egurbide I, Heras I, Poderós C, Martínez-Revuelta E, Guinea JM, del Potro E, Deben G. J Clin Oncol; 2007 Jan 01; 25(1):16-24. PubMed ID: 17194902 [Abstract] [Full Text] [Related]
4. Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia. Tsimberidou AM, Stavroyianni N, Viniou N, Papaioannou M, Tiniakou M, Marinakis T, Skandali A, Sakellari I, Yataganas X, Hellenic Cooperative Group. Cancer; 2003 Apr 01; 97(7):1721-31. PubMed ID: 12655529 [Abstract] [Full Text] [Related]
6. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95. Schrauder A, Reiter A, Gadner H, Niethammer D, Klingebiel T, Kremens B, Peters C, Ebell W, Zimmermann M, Niggli F, Ludwig WD, Riehm H, Welte K, Schrappe M. J Clin Oncol; 2006 Dec 20; 24(36):5742-9. PubMed ID: 17179108 [Abstract] [Full Text] [Related]
7. Intensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia: results of a prospective trial. Martino R, Bellido M, Brunet S, Altés A, Sureda A, Guárdia R, Aventín A, Nomdedéu JF, Domingo-Albós A, Sierra J. Haematologica; 1999 Jun 20; 84(6):505-10. PubMed ID: 10366793 [Abstract] [Full Text] [Related]
8. Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission. De Witte T, Awwad B, Boezeman J, Schattenberg A, Muus P, Raemaekers J, Preijers F, Strijckmans P, Haanen C. Bone Marrow Transplant; 1994 Nov 20; 14(5):767-74. PubMed ID: 7889010 [Abstract] [Full Text] [Related]
9. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study. Wahlin A, Billström R, Björ O, Ahlgren T, Hedenus M, Höglund M, Lindmark A, Markevärn B, Nilsson B, Sallerfors B, Brune M. Eur J Haematol; 2009 Aug 20; 83(2):99-107. PubMed ID: 19385987 [Abstract] [Full Text] [Related]
10. Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00. Bassan R, Rossi G, Pogliani EM, Di Bona E, Angelucci E, Cavattoni I, Lambertenghi-Deliliers G, Mannelli F, Levis A, Ciceri F, Mattei D, Borlenghi E, Terruzzi E, Borghero C, Romani C, Spinelli O, Tosi M, Oldani E, Intermesoli T, Rambaldi A. J Clin Oncol; 2010 Aug 01; 28(22):3644-52. PubMed ID: 20606084 [Abstract] [Full Text] [Related]
11. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG). Wrzesień-Kuś A, Robak T, Pluta A, Zwolińska M, Wawrzyniak E, Wierzbowska A, Skotnicki A, Jakubas B, Hołowiecki J, Nowak K, Kuliczkowski K, Mazur G, Haus O, Dmoszyńska A, Adamczyk-Cioch M, Jedrzejczak WW, Paluszewska M, Konopka L, Pałynyczko G. Ann Hematol; 2006 Jun 01; 85(6):366-73. PubMed ID: 16523310 [Abstract] [Full Text] [Related]
12. Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group. de Botton S, Fawaz A, Chevret S, Dombret H, Thomas X, Sanz M, Guerci A, San Miguel J, de la Serna J, Stoppa AM, Reman O, Stamatoulas A, Fey M, Cahn JY, Sotto JJ, Bourhis JH, Parry A, Chomienne C, Degos L, Fenaux P. J Clin Oncol; 2005 Jan 01; 23(1):120-6. PubMed ID: 15534358 [Abstract] [Full Text] [Related]
13. Autologous stem cell transplantation in acute myeloid leukemia. Factors influencing outcome. A 13 year single institution experience. Martins C, Lacerda JF, Lourenço F, Carmo JA, Lacerda JM. Acta Med Port; 2005 Jan 01; 18(5):329-37. PubMed ID: 16611537 [Abstract] [Full Text] [Related]
15. Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience. Hallböök H, Hägglund H, Stockelberg D, Nilsson PG, Karlsson K, Björkholm M, Linderholm M, Wahlin A, Linder O, Smedmyr B, Swedish Adult ALL Group. Bone Marrow Transplant; 2005 Jun 01; 35(12):1141-8. PubMed ID: 15834433 [Abstract] [Full Text] [Related]
16. Post-remission treatment for adult patients with acute lymphoblastic leukemia in first remission: is there a role for autologous stem cell transplantation? Willemze R, Labar B. Semin Hematol; 2007 Oct 01; 44(4):267-73. PubMed ID: 17961726 [Abstract] [Full Text] [Related]
17. Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial. Hunault M, Truchan-Graczyk M, Caillot D, Harousseau JL, Bologna S, Himberlin C, Guyotat D, Berthou C, Casassus P, Baranger L, Béné MC, Ifrah N, Gyan E, GOELAMS Group. Haematologica; 2007 Dec 01; 92(12):1623-30. PubMed ID: 18055985 [Abstract] [Full Text] [Related]
18. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group. Burkhardt B, Reiter A, Landmann E, Lang P, Lassay L, Dickerhoff R, Lakomek M, Henze G, von Stackelberg A. J Clin Oncol; 2009 Jul 10; 27(20):3363-9. PubMed ID: 19433688 [Abstract] [Full Text] [Related]
19. Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source. Ferrá C, Sanz J, de la Cámara R, Sanz G, Bermúdez A, Valcárcel D, Rovira M, Serrano D, Caballero D, Espigado I, Morgades M, Heras I, Solano C, Duarte R, Barrenetxea C, García-Noblejas A, Díez-Martin JL, Iriondo A, Carreras E, Sierra J, Sanz MA, Ribera JM, GETH (Grupo Español de Trasplante Hematopoyético) and PETHEMA (Programa Español de Tratamiento en Hematología), Spanish Society of Hematology. Biol Blood Marrow Transplant; 2010 Jul 10; 16(7):957-66. PubMed ID: 20144909 [Abstract] [Full Text] [Related]
20. [Comparison of the effectiveness of chemotherapy and autologous hematopoietic stem cell transplantation as postremission treatment for adult acute lymphoblastic leukemia patients]. Jin FY, Zou DH, Wang GR, Xu Y, Feng SZ, Zhao YZ, Han MZ, Yan WW, Qiu LG. Zhonghua Xue Ye Xue Za Zhi; 2005 Nov 10; 26(11):645-8. PubMed ID: 16620547 [Abstract] [Full Text] [Related] Page: [Next] [New Search]